| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |